Published: 26 May 2017
Author(s): Justine Serre, Chrystel François, Marie Claude Van der Haegen, Thomas Papo, Tiphaine Goulenok, Karim Sacre
Issue: May 2017
Section: Letter to the Editor

Streptococcus pneumoniae infection is a major cause of morbidity and mortality in patients with autoimmune inflammatory disorders (AID) treated with immunosuppressive therapy [1–4]. Despite international recommendations for pneumococcal vaccination in patients with AID [5], vaccination coverage remains worryingly low in this population [6,7].


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.